Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Body mass index procedure
|
252 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.700 | 1.000 | 1 | 2012 | 2012 | ||||
Finding of body mass index
|
252 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.700 | 1.000 | 1 | 2012 | 2012 | ||||
Obesity, Morbid
|
49 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Coronary heart disease
|
1178 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.090 | 0.778 | 9 | 2005 | 2013 | ||||
Hyperinsulinism
|
64 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.090 | 1.000 | 9 | 1999 | 2013 | ||||
Proliferative diabetic retinopathy
|
45 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Diabetes
|
710 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.100 | 0.813 | 32 | 2000 | 2014 | ||||
Non-alcoholic Fatty Liver Disease
|
222 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.090 | 0.778 | 9 | 2010 | 2014 | ||||
Malignant Neoplasms
|
1641 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.070 | 1.000 | 7 | 2001 | 2014 | ||||
Primary malignant neoplasm
|
1374 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.070 | 1.000 | 7 | 2001 | 2014 | ||||
Crohn Disease
|
1147 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.050 | 1.000 | 5 | 2008 | 2014 | ||||
Arteriosclerosis
|
267 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.030 | 1.000 | 3 | 2003 | 2014 | ||||
Atherosclerosis
|
281 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.030 | 1.000 | 3 | 2003 | 2014 | ||||
Ulcerative Colitis
|
827 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.030 | 0.667 | 3 | 2010 | 2014 | ||||
Arthritis, Psoriatic
|
89 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.020 | 1.000 | 2 | 2006 | 2014 | ||||
Fibrosis, Liver
|
64 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.020 | 1.000 | 2 | 2014 | 2014 | ||||
Lipodystrophy
|
28 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.020 | 0.500 | 2 | 2009 | 2014 | ||||
Malignant neoplasm of pancreas
|
277 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.020 | 1.000 | 2 | 2009 | 2014 | ||||
Metabolic Diseases
|
50 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.020 | 1.000 | 2 | 2007 | 2014 | ||||
Pancreatic carcinoma
|
322 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.020 | 1.000 | 2 | 2009 | 2014 | ||||
Rheumatoid Arthritis
|
2387 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.020 | 1.000 | 2 | 2014 | 2014 | ||||
CATARACT, ANTERIOR POLAR
|
27 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Hepatitis C
|
347 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Hodgkin Disease
|
148 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Human immunodeficiency virus (HIV) II infection category B1
|
56 | 0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 | 0.010 | 1.000 | 1 | 2014 | 2014 |